ALLR — Allarity Therapeutics Share News
0.000.00%
Last trade - 00:00- $13.77m
- $19.07m
- $0.32m
U.S. STOCKS ON THE MOVE-Oscar Health, Walgreens Boots, Alibaba Group
U.S. STOCKS ON THE MOVE-Oscar Health, Ciena, Lovesac
U.S. STOCKS ON THE MOVE-Walgreens Boots, Fusion Fuel, PVH Corp
Allarity Therapeutics fall on cancer studies readouts delay
Brief: Allarity Therapeutics Provides Updates For Ixempra And Stenoparib Phase 2 Monotherapy Clinical Studies
Brief: Allarity Therapeutics Announces Reverse Stock Split Of Common Stock
Brief: Allarity Therapeutics Doses First Patient In Phase 1B Clinical Trial Evaluating Dovitinib, Stenoparib Combination In Advanced Solid Tumors
Brief: Maier Joshua Tarlow Reports 9.98% Passive Stake In Allarity Therapeutics
Brief: Allarity Therapeutics-On Feb 8 Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard Transfer Of Listing From Nasdaq
Brief: Allarity Therapeutics Inc's Board Decreases Number Of Authorized Directors 7 To 5
Brief: Allarity Therapeutics Announces Adjournment Of 2023 Annual Meeting Of Stockholders
Brief: Allarity Therapeutics Receives Notice Of Delisting From Nasdaq
U.S. STOCKS ON THE MOVE-Energy firms, gold miners, Analog Devices
Brief: Allarity Therapeutics Reports Third Quarter 2022 Financial Results
Brief: Allarity Therapeutics Reports Second Quarter 2022 Financial Results
Brief: Allarity Therapeutics Appoints Biotechnology Executive Jerry McLaughlin To Board Of Directors
Brief: Allarity Therapeutics Receives Nasdaq Notification Of Non-Compliance With Listing Rule 5250(C)(1)
Allarity falls on going-concern warning
Brief: Allarity Therapeutics - Co Delinquent In Filing Form 10-Q For The Quarterly Period Ended June 30, 2022 With The SEC